Biology of the multidrug resistance-associated protein, MRP

https://doi.org/10.1016/0959-8049(96)00046-9Get rights and content

First page preview

First page preview
Click to open first page preview

References (188)

  • A Yoshimura et al.

    Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cells

    Biochem Biophys Acta

    (1989)
  • CL Ward et al.

    Intracellular turnover of cystic fibrosis transmembrane conductance regulator—inefficient processing and rapid degradation of wild-type and mutant proteins

    J Biol Chem

    (1994)
  • CI Ward et al.

    Degradation of CFTR by the ubiquitin-proteasome pathway

    Cell

    (1995)
  • MR Picciotto et al.

    Phosphorylation of the cystic fibrosis transmembrane conductance regulator

    J Biol Chem

    (1992)
  • TC Chambers et al.

    Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C

    J Biol Chem

    (1993)
  • GA Orr et al.

    Identification of the major phosphorylation domain of murine mdr1b P-glycoprotein analysis of the protein kinase A and protein kinase C phosphorylation sites

    J Biol Chem

    (1993)
  • BJ kuss et al.

    Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications

    Lancet

    (1994)
  • I Leier et al.

    The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates

    J Biol Chem

    (1994)
  • DWP Hay et al.

    Cysteinyl leukotrienes in asthma: old mediators up to new tricks

    Trends Pharmacol Sci

    (1995)
  • T Ishikawa et al.

    Glutathione-associated cisdiamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells

    J Biol Chem

    (1993)
  • RPJ Oude Elferink et al.

    The role of the canalicular multispecific organic anion transporter in the disposal of endoand xenobiotics

    Pharmacol Ther

    (1994)
  • TPM Akerboom et al.

    ATP-dependent S-(2,4-dinitrophenyl)glutathione transport in canalicular plasma membrane vesicles from rat liver

    J Biol Chem

    (1991)
  • T Ishikawa et al.

    ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membranes

    J Biol Chem

    (1990)
  • T Ishikawa

    ATP/Mg2+-dependent cardiac transport system for glutathione S-conjugates—a study using rat heart sarcolemma vesicles

    J Biol Chem

    (1989)
  • HJ Verkade et al.

    The uncoupling of biliary lipid from bile acid secretion by organic anions in the rat

    Gastroenterology

    (1990)
  • RPJ Oude Elferink et al.

    Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport

    Biochem Biophys Acta

    (1995)
  • S Ruetz et al.

    Functional expression of the multidrug resistance-associated protein (MRP) in the yeast Saccharomyces cerevisiae

    J Biol Chem

    (1996)
  • B Jovov et al.

    Cystic fibrosis transmembrane conductance regulator is required for protein kinase A activation of an outwardly rectified anion channel purified from bovine tracheal epithelia

    J Biol Chem

    (1995)
  • S.P.C. Cole

    Multidrug resistance in human lung cancer and topoisomerase II

  • M.M. Gottesman et al.

    Biochemistry of multidrug resistance mediated by the multidrug transporter

    Annu Rev Biochem

    (1993)
  • S.P.C. Cole

    The 1991 Merck Frosst award. Multidrug resistance in small cell lung cancer

    Can J Physiol Pharmacol

    (1992)
  • J.A. Endicott et al.

    The biochemistry of P-glycoproteinmediated multidrug resistance

    Annu Rev Biochem

    (1989)
  • S.P.C. Cole

    Drug resistance and lung cancer

  • K Ueda et al.

    Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine

  • P Gros et al.

    Isolation and expression of a complementary DNA that confers multidrug resistance

    Nature

    (1986)
  • J.R. Riordan et al.

    Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines

    Nature

    (1985)
  • C.R. Lincke et al.

    Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA

    Cancer Res

    (1990)
  • S.P.C. Cole et al.

    Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

    Science

    (1992)
  • S.P. Cole et al.

    Multidrug resistance-associated protein: sequence correction

    Science

    (1993)
  • C.E. Grant et al.

    Overexpression of multidrug resistanceassociated protein (MRP) increases resistance to natural product drugs

    Cancer Res

    (1994)
  • G.J.R. Zaman et al.

    The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump

  • G.D. Kruh et al.

    Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene

    Cancer Res

    (1994)
  • S.P.C. Cole et al.

    Multidrug resistance associated with Overexpression of MRP

  • C.F. Higgins

    ABC transporters: from microorganisms to man

    Annu Rev Cell Biol

    (1992)
  • S.P.C. Cole et al.

    Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells

    Cancer Res

    (1994)
  • M Muller et al.

    Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport

  • I Brock et al.

    Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells

    Cancer Res

    (1995)
  • S Hasegawa et al.

    Expression of multidrug resistance-associated protein (MRP), MDR1, and DNA Topoisomerase II in human multidrug-resistant bladder cancer cell lines

    Br J Cancer

    (1995)
  • K Nooter et al.

    Multidrug resistance (mdr) genes in human cancer

    Br J Cancer

    (1991)
  • I Pastan et al.

    Multidrug resistance

    Annu Rev Med

    (1991)
  • Cited by (409)

    • Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: In vitro and in vivo investigations

      2014, International Journal of Pharmaceutics
      Citation Excerpt :

      MDR is the most frequent phenomenon which poses a major obstacle towards curative therapy of various cancers, with ABC transporters having potential clinical importance as mediator of MDR. The three major ABC transporters involved in MDR are P-glycoprotein (Pgp) (Bansal et al., 2009), Multidrug resistance-associated protein (MRP) and breast cancer resistance protein (BCRP) which are responsible for poor prognosis in tumors (Loe et al., 1996). The efflux transporters pump out the chemotherapeutic drug from cancer cells, thus decreasing the intracellular drug accumulation and hence conferring MDR in cancer cells.

    • Natural and Acquired Resistance to Cancer Therapies

      2015, The Molecular Basis of Cancer: Fourth Edition
    View all citing articles on Scopus
    View full text